PEAK6 Investments’s BeOne Medicines Ltd ONC Stock Holding History

PEAK6 Investments’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,000	Closed	-$285K	–	4177
2024 Q2	$285K	Buy	+2,000	New	+$308K	﹤0.01%	2579
2023 Q3	–	Sell	-999	Closed	-$178K	–	4680
2023 Q2	$178K	Buy	999 +695	+229%	+$160K	﹤0.01%	2947
2023 Q1	$65.4K	Buy	+304	New	+$72.9K	﹤0.01%	3673
2022 Q3	–	Sell	-999	Closed	-$178K	–	5780
2022 Q2	$178K	Buy	999 +535	+115%	+$83.6K	﹤0.01%	2948
2022 Q1	$88K	Buy	+464	New	+$98.6K	﹤0.01%	4359
2019 Q4	–	Sell	-1,962	Closed	-$240K	–	4195
2019 Q3	$240K	Buy	1,962 +256	+15%	+$34K	﹤0.01%	2784
2019 Q2	$211K	Buy	+1,706	New	+$217K	﹤0.01%	2828
2019 Q1	–	Sell	-2,900	Closed	-$391K	–	4731
2018 Q4	$407K	Buy	2,900 +49	+2%	+$6.5K	﹤0.01%	2515
2018 Q3	$491K	Buy	+2,851	New	+$479K	﹤0.01%	2580

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

PEAK6 Investments's ONC Position: Q3 2024 in Review

PEAK6 Investments sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 2,000 shares — an estimated $285K sold.

PEAK6 Investments first reported a position in ONC in Q3 2018 and held it in 9 quarters. The position peaked at $491K in Q3 2018. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

PEAK6 Investments reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
PEAK6 Investments sold 2,000 BeOne Medicines Ltd shares in Q3 2024, an estimated $285K.
PEAK6 Investments first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 9 quarters.
PEAK6 Investments's BeOne Medicines Ltd position peaked at $491K in Q3 2018.
228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.